Home/Cipla/Mr. Geena Malhotra
MG

Mr. Geena Malhotra

Global Chief Technology Officer

Cipla

Cipla Pipeline

DrugIndicationPhase
Respiratory Inhalation Portfolio (Generic)Asthma, COPDANDA Filed/Approved
Bevacizumab BiosimilarVarious Cancers (Colorectal, Lung, etc.)Phase III / Registration
Pembrolizumab BiosimilarVarious CancersEarly Development
Complex Generic Oncology InjectablesBreast Cancer, Pancreatic CancerANDA Filed/Approved